Skip to main content
Top
Published in: Neurological Sciences 7/2018

01-07-2018 | Original Article

Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients

Authors: Reza Fekrazad, Ahmadreza Sardarian, Kamran Azma, Masoumeh Karami, Afshin Borhani-Haghighi, Behrouz Gharesi-Fard, Bahram Movahedi

Published in: Neurological Sciences | Issue 7/2018

Login to get access

Abstract

Calcitonin gene related peptide (CGRP) is a mediator of neurogenic inflammation playing a major role in the pathogenesis of migraine. Increases in serum CGRP have been detected previously in migraineurs and a return to baseline values regarded as successful treatment. As gingival crevicular fluid is known to originate from the serum, the aim of this study is to measure the CGRP content of gingival crevicular fluid (GCF) in chronic migraine patients and to determine whether there is a correlation between serum and GCF values of CGRP. For this study, 24 female individuals suffering from chronic migraine with aura were age-matched with 15 healthy individuals. Serum and GCF samples were obtained from both groups and enzyme linked immunosorbent assay performed to measure CGRP concentration. The level of CGRP in the serum and GCF of chronic migraine patients was 41 ± 16 pg/mL and 0.25 ± 0.09 pg/μg respectively while in healthy individuals CGRP levels were 29 ± 8 pg/mL and 0.19 ± 0.07 pg/μg. The correlation between CGRP levels of the GCF and serum was 0.88 for migraineurs and 0.81 in the controls. Only a weak positive relationship was observed between age and CGRP levels in both groups. CGRP levels were higher in migraineurs compared with controls both in serum and GCF. Furthermore there is a strong correlation between CGRP levels of the serum and GCF. The results of this study suggest that CGRP levels of GCF have potential diagnostic purposes in patients with chronic migraine.
Literature
1.
go back to reference Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA 267:64–69CrossRefPubMed Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA 267:64–69CrossRefPubMed
2.
go back to reference Moskowitz MA (1991) The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 41:182–186CrossRefPubMed Moskowitz MA (1991) The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 41:182–186CrossRefPubMed
3.
go back to reference Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56CrossRefPubMed Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56CrossRefPubMed
4.
go back to reference Goadsby PJ, Edvisnson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183–187CrossRefPubMed Goadsby PJ, Edvisnson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183–187CrossRefPubMed
5.
go back to reference Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Brain Res Rev 48:438–456CrossRefPubMed Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Brain Res Rev 48:438–456CrossRefPubMed
6.
go back to reference Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32CrossRefPubMedPubMedCentral Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32CrossRefPubMedPubMedCentral
7.
go back to reference Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attack therapies. Brain 117:427–434CrossRefPubMed Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attack therapies. Brain 117:427–434CrossRefPubMed
8.
go back to reference Cernuda-Morollón E, Larrosa D, Ramón C et al (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81:1191–1196CrossRefPubMed Cernuda-Morollón E, Larrosa D, Ramón C et al (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81:1191–1196CrossRefPubMed
9.
go back to reference Ashina M, Bendtsen L, Jensen R, Schifter S, Jansen-Olesen I, Olesen J (2000) Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 55:1335–1340CrossRefPubMed Ashina M, Bendtsen L, Jensen R, Schifter S, Jansen-Olesen I, Olesen J (2000) Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 55:1335–1340CrossRefPubMed
10.
go back to reference Frese A, Schilgen M, Edvinsson L, Frandsen E, Evers S (2005) Calcitonin gene-related peptide in cervicogenic headache. Cephalalgia 25:700–703CrossRefPubMed Frese A, Schilgen M, Edvinsson L, Frandsen E, Evers S (2005) Calcitonin gene-related peptide in cervicogenic headache. Cephalalgia 25:700–703CrossRefPubMed
11.
go back to reference Cady RK, Vause CV, Ho TW, Bigal ME, Durham PL (2009) Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache: J Head Face Pain 49:1258–1266CrossRef Cady RK, Vause CV, Ho TW, Bigal ME, Durham PL (2009) Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache: J Head Face Pain 49:1258–1266CrossRef
12.
go back to reference Jang MU, Park JW, Kho HS, Chung SC, Chung JW (2011) Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis 17:187–193CrossRefPubMed Jang MU, Park JW, Kho HS, Chung SC, Chung JW (2011) Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis 17:187–193CrossRefPubMed
13.
go back to reference Kaufman E, Lamster IB (2002) The diagnostic applications of saliva—a review. CROBM 13:197–212 Kaufman E, Lamster IB (2002) The diagnostic applications of saliva—a review. CROBM 13:197–212
14.
go back to reference Leppilahti JM, Hernández-Ríos PA, Gamonal JA, Tervahartiala T, Brignardello-Petersen R, Mantyla P, Sorsa T, Hernández M (2014) Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol 41:348–356CrossRefPubMed Leppilahti JM, Hernández-Ríos PA, Gamonal JA, Tervahartiala T, Brignardello-Petersen R, Mantyla P, Sorsa T, Hernández M (2014) Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol 41:348–356CrossRefPubMed
15.
go back to reference Ehlers V, Willershausen I, Kraft J, Münzel T, Willershausen B (2011) Gingival crevicular fluid MMP-8-concentrations in patients after acute myocardial infarction. Head Face Med 7:1CrossRefPubMedPubMedCentral Ehlers V, Willershausen I, Kraft J, Münzel T, Willershausen B (2011) Gingival crevicular fluid MMP-8-concentrations in patients after acute myocardial infarction. Head Face Med 7:1CrossRefPubMedPubMedCentral
16.
go back to reference Yamaguchi M, Takada R, Kambe S, Hatakeyama T, Naitoh K, Yamazaki K, Kobayashi M (2005) Evaluation of time-course changes of gingival crevicular fluid glucose levels in diabetics. Biomed Microdevices 7:53–58CrossRefPubMed Yamaguchi M, Takada R, Kambe S, Hatakeyama T, Naitoh K, Yamazaki K, Kobayashi M (2005) Evaluation of time-course changes of gingival crevicular fluid glucose levels in diabetics. Biomed Microdevices 7:53–58CrossRefPubMed
17.
go back to reference Noguchi E, Kato R, Ohno K, Mitsui A, Obama T, Hirano T, Itabe H, Yamamoto M (2014) The apolipoprotein B concentration in gingival crevicular fluid increases in patients with diabetes mellitus. Clin Biochem 47:67–71CrossRefPubMed Noguchi E, Kato R, Ohno K, Mitsui A, Obama T, Hirano T, Itabe H, Yamamoto M (2014) The apolipoprotein B concentration in gingival crevicular fluid increases in patients with diabetes mellitus. Clin Biochem 47:67–71CrossRefPubMed
18.
go back to reference Awawdeh LA, Lundy FT, Linden GJ, Shaw C, Kennedy JG, Lamey PJ (2002) Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in gingival crevicular fluid associated with painful human teeth. Eur J Oral Sci 110:185–191CrossRefPubMed Awawdeh LA, Lundy FT, Linden GJ, Shaw C, Kennedy JG, Lamey PJ (2002) Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in gingival crevicular fluid associated with painful human teeth. Eur J Oral Sci 110:185–191CrossRefPubMed
19.
go back to reference Lundy FT, Shaw C, McKinnell J, Lamey PJ, Linden GJ (1999) Calcitonin gene-related peptide in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol 26:212–216CrossRefPubMed Lundy FT, Shaw C, McKinnell J, Lamey PJ, Linden GJ (1999) Calcitonin gene-related peptide in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol 26:212–216CrossRefPubMed
20.
go back to reference Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J (2015) OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 156:820–824CrossRefPubMed Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J (2015) OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 156:820–824CrossRefPubMed
21.
go back to reference Becerik S, Ozçaka O, Nalbantsoy A et al (2010) Effects of menstrual cycle on periodontal health and gingival crevicular fluid markers. J Periodontol 81:673–681CrossRefPubMed Becerik S, Ozçaka O, Nalbantsoy A et al (2010) Effects of menstrual cycle on periodontal health and gingival crevicular fluid markers. J Periodontol 81:673–681CrossRefPubMed
22.
go back to reference Sardarian A, Andisheh Tadbir A, Zal F, Amini F, Jafarian A, Khademi F, Mostafavi-Pour Z (2015) Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells. Toxicol Mech Methods 25:98–104CrossRefPubMed Sardarian A, Andisheh Tadbir A, Zal F, Amini F, Jafarian A, Khademi F, Mostafavi-Pour Z (2015) Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells. Toxicol Mech Methods 25:98–104CrossRefPubMed
23.
go back to reference Bigal ME, Liberman JN, Lipton RB (2006) Age-dependent prevalence and clinical features of migraine. Neurology 67:246–251CrossRefPubMed Bigal ME, Liberman JN, Lipton RB (2006) Age-dependent prevalence and clinical features of migraine. Neurology 67:246–251CrossRefPubMed
24.
go back to reference Koka S, Beebe TJ, Merry SP, DeJesus RS, Berlanga LD, Weaver AL, Montori VM, Wong DT (2008) The preferences of adult outpatients in medical or dental care settings for giving saliva, urine or blood for clinical testing. J Am Dent Assoc 139:735–740CrossRefPubMedPubMedCentral Koka S, Beebe TJ, Merry SP, DeJesus RS, Berlanga LD, Weaver AL, Montori VM, Wong DT (2008) The preferences of adult outpatients in medical or dental care settings for giving saliva, urine or blood for clinical testing. J Am Dent Assoc 139:735–740CrossRefPubMedPubMedCentral
25.
go back to reference Diener HC, Charles A, Goadsby PJ, Holle D (2015) New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol 14:1010–1022CrossRefPubMed Diener HC, Charles A, Goadsby PJ, Holle D (2015) New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol 14:1010–1022CrossRefPubMed
26.
go back to reference Edvinsson L (2015) The journey to establish CGRP as a migraine target: a retrospective view. Headache 55:1249–1255CrossRefPubMed Edvinsson L (2015) The journey to establish CGRP as a migraine target: a retrospective view. Headache 55:1249–1255CrossRefPubMed
27.
28.
go back to reference Wrobel Goldberg S, Silberstein SD (2015) Targeting CGRP: a new era for migraine treatment. CNS Drugs 29:443–452CrossRefPubMed Wrobel Goldberg S, Silberstein SD (2015) Targeting CGRP: a new era for migraine treatment. CNS Drugs 29:443–452CrossRefPubMed
30.
go back to reference Barbanti P, Aurilia C, Fofi L, Egeo G, Ferron P (2017) The role of anti-CGRP antibodies in the pathophysiology of primary headaches. Neurol Sci 38(Supplement 1):31–35CrossRefPubMed Barbanti P, Aurilia C, Fofi L, Egeo G, Ferron P (2017) The role of anti-CGRP antibodies in the pathophysiology of primary headaches. Neurol Sci 38(Supplement 1):31–35CrossRefPubMed
31.
go back to reference Giamberardino MA, Affaitati G, Curto M, Negro A, Costantini A (2016) Martelletti P (2016) Anti-CGRP monoclonal antibodies in migraine: current perspectives. Intern Emerg Med 11:1045–1057CrossRefPubMed Giamberardino MA, Affaitati G, Curto M, Negro A, Costantini A (2016) Martelletti P (2016) Anti-CGRP monoclonal antibodies in migraine: current perspectives. Intern Emerg Med 11:1045–1057CrossRefPubMed
33.
go back to reference Maasumi K, Tepper SJ, Rapoport AM (2017) New treatments for headache. Neurol Sci 38(Supplement 1):145–156CrossRefPubMed Maasumi K, Tepper SJ, Rapoport AM (2017) New treatments for headache. Neurol Sci 38(Supplement 1):145–156CrossRefPubMed
Metadata
Title
Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients
Authors
Reza Fekrazad
Ahmadreza Sardarian
Kamran Azma
Masoumeh Karami
Afshin Borhani-Haghighi
Behrouz Gharesi-Fard
Bahram Movahedi
Publication date
01-07-2018
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 7/2018
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3340-3

Other articles of this Issue 7/2018

Neurological Sciences 7/2018 Go to the issue